Neuralink has received approval to perform brain implants on patients in Canada

The company Neuralink will conduct the first clinical trials outside the US. It has received approval from Canadian authorities to begin human trials, and Toronto Western Hospital will be the first and exclusive site to perform the surgical procedures.

In March of this year, Neuralink opened a patient registry in Canada and is now seeking potential trial participants. According to the study called CAN-PRIME, the company aims to implant the device in the human brain to interpret neuronal activity. This implant will enable people to control a computer or smartphone with just their thoughts, without the need for cables or physical movement.

Neuralink explains that the purpose of the study is to evaluate the safety of the implant and the surgical robot, as well as the initial functionality of the computer-brain interface, writes engadget.

The aim is to enable people with total limb paralysis to control external devices through thought. The benefits of these tests can help the company find safer ways to install the implant and develop the technology.

The first patient to receive an implant from Neuralink earlier this year experienced some complications due to the implant's threads moving out of the brain, but is now reported to be doing well. Through social network X, he has announced that he will soon undertake a 72-hour challenge to demonstrate the capabilities of Neuralink technology.

For the second patient, the company has taken measures to prevent previous problems. This patient is already using computer-aided design (CAD) software just weeks after surgery, which was performed in July.

Neuralink is currently seeking patients with disabilities or complete loss of the use of both hands, due to spinal cord injury in the neck or due to the disease ALS (Amyotrophic Lateral Sclerosis), to include them in her research in Canada. /Telegraph/